Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Changes in operating assets and liabilities:
Net income (loss)	$ 14,136	$ (8,666)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	1,356	897
Gain on sales-type leases		(99)
Provision for doubtful accounts	292	10
Loss on disposal of fixed assets		59
Write down of inventories		124
Amortization of convertible notes	1,490	251
Gain (loss) on change in fair value of derivative liability	(602)	25
Loss on warrants issued during private placements	7,432
Gain on change in fair value of warrant liability	(14,402)
Share-based compensation	5	202
Impairment loss on goodwill	4,271
Warranty reserve	(935)	(30)
Amortization of right-of-use assets	718	565
Bargain purchase gain	(32,072)
Deferred tax liability reversal	(5,223)
Changes in operating assets and liabilities:
Accounts receivable	(5,433)	442
Inventories	15,543	1,901
Battery lease receivables	545
Prepaid expenses and other assets	(847)	989
Accounts payable	1,320	604
Accrued liabilities	4,832	20
Deferred revenue	(15)	(23)
Advance from customers	4,926	886
Lease liabilities	(1,148)	(735)
Net investment in leases	154
Amount due from related party	107	36
Income tax payable	736
Net cash used in operating activities	(2,814)	(2,542)
Cash flows from investing activities:
Purchase of property and equipment	(113)	(162)
Loan lent to a related party	(2,566)	(400)
Proceeds from repayment from a related party	2,566	400
Acquisition of Proterra	(10,000)
Net cash used in investing activities	(10,113)	(162)
Cash flows from financing activities:
Repayment of borrowings	(4,703)
Proceeds from convertible notes		1,464
Proceeds from borrowings	4,982
Repayment of related party borrowings	(1,914)	(481)
Proceeds from related party borrowings	1,051	541
Proceeds received from private placements	11,104
Repayment of convertible notes	(597)
Proceeds received from standby equity purchase agreement		1,227
Net cash generated from financing activities	9,923	2,751
(Decrease) increase in cash, cash equivalents and restricted cash	(3,004)	47
Cash, cash equivalents and restricted cash at beginning of the period	3,283	389
Cash, cash equivalents and restricted cash at end of the period	279	436
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	279	186
Restricted Cash, Current		250
Total cash, cash equivalents, and restricted cash	279	436
Supplemental cash flow information:
Income tax paid
Non-cash activities:
Derivative liabilities recorded as debt discount		294
Issuance of common stock for convertible note conversion	1,293
Reclass of derivative liability to additional paid-in capital upon conversion of related convertible notes	317
Issuance of common stock to Wisdom Financial to repay the consulting fee	270
Issuance of common stock for settlement with vendors	1,693
Inventories transferred to property and equipment		$ 497